Cytomegalovirus immune globulin (CMVIG) in combination with gancyclovir provides cost-effective prophylaxis of CMV after lung transplantation (LTX)
- 1 January 1999
- journal article
- abstracts
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 18 (1) , 81